Home
Live Updates
AIM ImmunoTech Provides Summary of Ampligen® Data : comparemela.com
AIM ImmunoTech Provides Summary of Ampligen® Data
Ampligen has demonstrated in pre-clinical and now human clinical studies a potential to enhance efficacy of PD-1 and/or PD-L1 checkpoint inhibitors ...
Related Keywords
United States ,
American ,
Pawel Kalinski ,
Jenene Thomas ,
Michael Tony Hollingsworth ,
Roswell Park ,
Bob Edwards ,
Robert Edwards ,
Thomas Equels ,
Roswell Park Comprehensive Cancer Center ,
Immunotech Inc ,
University Of Nebraska Medical Center ,
University Of Pittsburgh Medical Center ,
University Of Pittsburgh School Medicine ,
University Of Pittsburgh Cancer Institute ,
Buffett Cancer Center ,
Division Of Translational Immuno ,
Steam Science ,
Chief Executive Officer ,
Associate Director ,
Basic Research ,
Nebraska Medical ,
Pittsburgh School ,
Pittsburgh Cancer ,
Jacobs Family Endowed Chair ,
Translational Immuno Oncology ,
Senior Vice President ,
Roswell Park Comprehensive Cancer ,
Ovarian Cancer ,
Pittsburgh Medical Center ,
Negative Breast Cancer ,
Private Securities Litigation Reform Act ,
Nyse Aim ,
Aim Immunotech Inc ,
Dancer ,
comparemela.com © 2020. All Rights Reserved.